Article
Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jun 2024
Godley Lucy A, DiNardo Courtney D, Bolton Kelly
Abstract excerpt
Although numerous barriers for clinical germline cancer predisposition testing exist, the increasing recognition of deleterious germline DNA variants contributing to myeloid malignancy risk is yielding steady improvements in referrals for testing and testing availability. Many germline predisposition alleles are common in populations, and the increasing number of recognized disorders makes inherited myeloid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
